This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2009 Mar 5;360(10):994-1001.

doi: 10.1056/NEJMcp0806317.

Clinical practice. Graves' ophthalmopathy

Luigi Bartalena¹, Maria Laura Tanda

Affiliations

PMID: 19264688
DOI: 10.1056/NEJMcp0806317

Review

Clinical practice. Graves' ophthalmopathy

Luigi Bartalena et al. N Engl J Med. 2009.

. 2009 Mar 5;360(10):994-1001.

doi: 10.1056/NEJMcp0806317.

Authors

Luigi Bartalena¹, Maria Laura Tanda

Affiliation

¹ Department of Clinical Medicine, University of Insubria, Varese, Italy. luigi.bartalena@uninsubria.it

PMID: 19264688
DOI: 10.1056/NEJMcp0806317

No abstract available

PubMed Disclaimer

Similar articles

Graves' disease: clinical pathophysiology, presentation and treatment options.
Holt K. Holt K. J Pract Nurs. 2010 Fall;60(3):13-8. J Pract Nurs. 2010. PMID: 21175104 No abstract available.
Do glucocorticoids affect outcome in Graves' disease following radioiodine therapy?
Salvatore D, Fenzi G. Salvatore D, et al. Nat Clin Pract Endocrinol Metab. 2006 Apr;2(4):194-5. doi: 10.1038/ncpendmet0163. Nat Clin Pract Endocrinol Metab. 2006. PMID: 16932282 No abstract available.
[Management of Graves' orbitopathy: evidence-based recommendations].
Ponto KA, Pitz S, Mann WJ, Weber MM, Pfeiffer N, Kahaly GJ. Ponto KA, et al. Dtsch Med Wochenschr. 2009 Dec;134(49):2521-4. doi: 10.1055/s-0029-1243057. Epub 2009 Nov 25. Dtsch Med Wochenschr. 2009. PMID: 19941237 German.
Optimal management of Graves orbitopathy: a multidisciplinary approach.
Soeters MR, van Zeijl CJ, Boelen A, Kloos R, Saeed P, Vriesendorp TM, Mourits MP. Soeters MR, et al. Neth J Med. 2011 Jul-Aug;69(7):302-8. Neth J Med. 2011. PMID: 21934174 Review.
Graves' Disease.
Smith TJ, Hegedüs L. Smith TJ, et al. N Engl J Med. 2016 Oct 20;375(16):1552-1565. doi: 10.1056/NEJMra1510030. N Engl J Med. 2016. PMID: 27797318 Review. No abstract available.

See all similar articles

Cited by

Intravenous rituximab therapy for active Graves' ophthalmopathy: a meta-analysis.
Chen J, Chen G, Sun H. Chen J, et al. Hormones (Athens). 2021 Jun;20(2):279-286. doi: 10.1007/s42000-021-00282-6. Epub 2021 Mar 30. Hormones (Athens). 2021. PMID: 33783712 Review.
Rituximab therapy in steroid-resistant severe hypothyroid Grave's ophthalmopathy.
Pandit A, Gundgurthi A, Kharb S, Brar KS, Garg MK. Pandit A, et al. Indian J Endocrinol Metab. 2013 Mar;17(2):344-8. doi: 10.4103/2230-8210.109669. Indian J Endocrinol Metab. 2013. PMID: 23776919 Free PMC article.
Intestinal permeability is associated with aggravated inflammation and myofibroblast accumulation in Graves' orbitopathy: the MicroGO study.
Fenneman AC, van der Spek AH, Hartstra A, Havik S, Salonen A, de Vos WM, Soeters MR, Saeed P, Nieuwdorp M, Rampanelli E. Fenneman AC, et al. Front Endocrinol (Lausanne). 2023 Nov 30;14:1173481. doi: 10.3389/fendo.2023.1173481. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 38107520 Free PMC article.
Thyroid Eye Disease: Navigating the New Treatment Landscape.
Dosiou C, Kossler AL. Dosiou C, et al. J Endocr Soc. 2021 Mar 17;5(5):bvab034. doi: 10.1210/jendso/bvab034. eCollection 2021 May 1. J Endocr Soc. 2021. PMID: 33948524 Free PMC article.
Cavernous Sinus Dural Arteriovenous Fistula in a Patient with Thyroid-Associated Ophthalmopathy: Complete Resolution after Medical Treatment.
Cavasin N, Presotto F, Bellamio M, Cagliari E. Cavasin N, et al. Brain Sci. 2021 Dec 29;12(1):45. doi: 10.3390/brainsci12010045. Brain Sci. 2021. PMID: 35053788 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information